Showing results (41-50 of 239) with videos related to
Sort By:
Pageof 24
Psychopharmacology Communications|January 1, 1975
Ascorbic acid levels in chronic psychotic patientsP Clement, T A Ban, H E LehmannInternational Pharmacopsychiatry|January 1, 1978
A review of nicotinic acid, N-methylated indoleamines and schizophreniaD Luchins, T A Ban, H E LehmannInternational Pharmacopsychiatry|January 1, 1980
Amoxapine: a review of literatureT A Ban, W H Wilson, J P McEvoyThe Journal of Clinical Psychiatry|February 1, 1980
Possible lack of anticholinergic effects with mianserin: a pilot studyW H Wilson, W M Petrie, T A BanInternational Pharmacopsychiatry|January 1, 1978
Butaclamol in the treatment of schizophrenia. A standard-controlled clinical trialJ N Nestoros, H E Lehmann, T A BanInternational Pharmacopsychiatry|January 1, 1981
The use of nicotinic acid and pyridoxine in the treatment of schizophreniaW M Petrie, T A Ban, J V AnanthInternational Pharmacopsychiatry|January 1, 1975
Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161)H E Lehmann, T A Ban, G V SchwartzInternational Pharmacopsychiatry|January 1, 1977
Transmethylation hypothesis of schizophrenia: methionine and nicotinic acidJ N Nestoros, T A Ban, H E LehmannArchives of Sexual Behavior|October 1, 1981
Sexual behavior of the male schizophrenic: the impact of illness and medicationsJ N Nestoros, H E Lehmann, T A BanThe Pavlovian Journal of Biological Science|January 1, 1979
Conditioning and the classification of the chronic schizophrenic patientT A Ban, J V Ananth, H E LehmannPageof 24